Related Experiment Video

Updated: Jun 2, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

Design, synthesis, and biological activity of novel Magmas inhibitors

Paul T Jubinsky1, Mary K Short, Mohmoud Ghanem

  • 1Pediatric Hematology/Oncology, Yale University Medical School, New Haven, CT 06510, United States. paul.jubinsky@yale.edu

Bioorganic & Medicinal Chemistry Letters
|April 26, 2011
PubMed

Insights

Researchers developed small molecule Magmas inhibitors (SMMI) to study the essential gene Magmas. Compound 9 effectively inhibited yeast growth and demonstrated specific binding to Magmas, offering a new tool for Magmas research.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Yeast Genetics

Background:

  • Magmas (mitochondria associated, granulocyte-macrophage colony stimulating factor signaling molecule) is a vital, conserved gene present in all cell types.
  • Understanding Magmas function is crucial for cellular processes.

Purpose of the Study:

  • To design and synthesize novel small molecule Magmas inhibitors (SMMI).
  • To evaluate the efficacy of SMMIs in inhibiting yeast proliferation.
  • To characterize the binding affinity and specificity of lead compounds to Magmas.

Main Methods:

  • Chemical synthesis of small molecules.
  • Yeast proliferation assays to assess growth inhibition.
  • Fluorometric titration to determine binding constants (Kd).
  • Genetic studies and molecular modeling for target specificity validation.

Main Results:

  • Several SMMIs were synthesized and tested.
  • Compound 9 demonstrated significant growth inhibition in yeast at a 4 μM concentration.
  • Compound 9 exhibited a dissociation constant (Kd) of 33 μM for Magmas.
  • Direct binding and genetic studies confirmed the target specificity of Compound 9.

Conclusions:

  • Small molecule inhibitors targeting Magmas can be effectively developed.
  • Compound 9 represents a potent and specific inhibitor of Magmas.
  • This study provides a valuable chemical probe for further investigation of Magmas biology.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Related Concept Videos

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...